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transplant and had both kidneys treated. One week after cystoscopy aided transurethral
treatment with the NephroBlate device, the previously planned nephrectomy was
performed. Following this we treated 4 resistant hypertensive patients.
Results: Nephrectomy Patients – Procedure time was between 9 to 15 min., and no
adverse effects were recorded. The histopathological results of the treated kidney in all
cases showed a signiﬁcant destruction of the peri-pelvic nerves from the renal pelvic
space to the serosa (1.75mm). We then proceeded with our clinical studies on resistant
hypertensive patients. Resistant Hypertensive Patients – Four patients were treated
utilizing a standard urologic procedure with OR times of 16-25 min. Within 30 seconds
of treatment of the ﬁrst kidney, a blood pressure response was noted (reduction of mean
systolic blood pressure 44mmHg, reduction ofmean diastolic blood pressure 13mmHg).
Following the procedure, none of the patients had signiﬁcant pain or bleeding.
Conclusions: At six month follow-up, the patients continue to be normotensive with
no renal issues. The blood pressure response was immediate and occurred while the
patients were under general anesthesia. In this small series of humans treated with
limited follow-up, we see a promising nonvascular alternative for renal denervation
for treatment for resistant.
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Background: Catheter-based renal denervation (RDN) has demonstrated efﬁcacy in
controlling blood pressure in clinical trials. The long-term effect in blood pressure and
nerve “regrowth” has been questioned. We aimed to study and characterize the renal
nerve response following RDN acutely and long term.
Methods: Swine underwent bilateral RDN and they were followed for 7, 30, 90 and
180 days. At each time point renal arteries were harvested for further histological
analysis. A representative section of each time point was selected for regular H&E
staining and immunohistochemical (IHC) analysis. The IHC evaluation of the renal
arteries consisted on S100 (Schwann cell), Tyrosine hydroxylase (TH; efferent motor
renal nerves), calcitonin gene-related peptide (CGRP) and substance P (SP); (CGRP
and SP afferent sensory renal nerves) to provide a complete characterization of the
nerve response to treatment over time.
Results: H&E stain displayed a nerve injury in acute (7 days: nerve necrosis, distal
atrophy) and chronic follow up (180 days: nerve ﬁbrosis). At the longer time points
H&E displayed nerve remodeling and tentative regeneration. At chronic time points
there was morphological recovery of S100, TH, CGRP and SP. However, there was
evidence of TH and S100 staining and extension of neural bundles within and across
the thickened perineurium, forming neuroﬁbrous tangles (perineural neuromatous
regeneration, PNR). IHC revealed TH and S100 positive ﬁbers within and beyond the
ﬁbrous perineurium as early as 7 days post-RDN. This PNR becomes more evident at
longer time points. At 180 days, these neuromatous tangles became very prominent to
the point of being evident with HE where affected nerves were sometimes completely
remodeled into neuromatous proliferative bundles.
Conclusions: Nerves regeneration has been demonstrated in renal transplant models.
Long term follow up has demonstrated nerve count increase following RDN in pre-
clinical studies. We demonstrate that this “regenerative nerve attempt” occurs as early
as 7 days post-RDN resulting in a poorly organized tangles of nerve ﬁbers and con-
nective tissue. This is the ﬁrst complete histological characterization of neuromatous
nerve regrowth following RDN.
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Background: The Kona Medical Surround Sound System is a noninvasive treat-
ment for renal denervation and delivers externally focused ultrasound to the renal
nerves using Doppler based ultrasound image guidance to track and correct for renal
artery motion during treatment.
Methods: Twenty-three patients with severe treatment resistant hypertension, deﬁned
as persistent systolic blood pressure (SBP) greater than 160 mmHg despite three or
more antihypertensive medications, were treated non-invasively with the Kona
Medical Surround Sound System to evaluate the safety and feasibility of a novel
approach to this treatment for renal denervation. Focused ultrasound energy was
delivered to the proximal renal arteries and surrounding tissue using non-invasiveJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/HyDoppler-based imaging and continuous tracking with automatic correction for kidney
motion throughout treatment. All patients received conscious sedation during treat-
ment and tolerated treatment well.
Results: Fourteen patients completed at least the 6-Week Follow-up Visit, and three
subjects completed the 24-Week Follow-up Visit. No serious device related events
have been reported during treatment or during the initial three week follow-up period.
Six patients reported mild, clinically insigniﬁcant back pain immediately following
treatment with complete resolution within 24 hours in a majority of patients. One
patient developed post-procedural transient hypokalemia, probably unrelated to renal
denervation, which resolved with potassium replacement. Of the 14 patients who have
completed 6-Week Follow-up Visits, 11 (78.6%) achieved a systolic blood pressure
(SBP) decrease of at least 10 mmHg, with an average SBP decrease of 23 mmHg and
an average diastolic blood pressure decrease of 9 mmHg.
Conclusions: Initial results of this fully non-invasive renal denervation system
demonstrated it was well tolerated and safely delivered in 23 patients. Doppler-based
image guidance for targeting and continuous tracking with automatic motion
correction enabled patients to beneﬁt from renal denervation therapy without the
invasive risks associated with catheter based renal denervation.
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Background: The Paradise Renal Denervation System (ReCor Medical, Palo Alto,
CA) is designed to deliver ultrasound (US) energy to perform circumferential
denervation of the renal sympathetic nerves. As current renal denervation systems do
not allow for immediate biofeedback to the user regarding effective denervation, it is
critical to generate mechanism of action data. We demonstrate in a preclinical model
and in humans that US denervation decreases sympathetic nerve activity post pro-
cedure, which should to translate into potential clinical beneﬁt in humans.
Methods: Bilateral ultrasound renal denervation was performed in 8 normotensive
pigs. Pigs received 1, 2, or 3 bilateral US emissions. At 7 days, kidney norepinephrine
(NEPI) levels were measured by HPLC/MS to assess sympathetic nerve activity, and
renal nerve injury was assessed histologically. MSNA data was collected at baseline
and one month post procedure in 5 patients enrolled in the REALISE trial in France.
Patients received 2 or 3 bilateral US emissions. Ofﬁce BP was recorded at 1 month
and correlations between BP and MSNA reduction performed.
Results: Kidney NEPI levels were signiﬁcantly reduced in all animals and correlated
with the degree of nerve damage. 2 or 3 bilateral ultrasound emissions resulted in 89%
or 97% NEPI reduction, respectively. A reduction in NEPI 89% correlated with
ablation of 76% of nerves along the length of the renal artery. In humans, a reduction
in MSNA was observed in all 5 patients (mean 17%) 1 month following US dener-
vation. The decrease in MSNA correlated with a decrease in BP 10mmHg in 4 of
5 patients suggesting that US is effective in reducing sympathetic nerve activity,
which may translate into clinical beneﬁt in a subset of patients.
Conclusions: Translational data is critical towards understanding the mechanism of
action associated with renal denervation devices. Ultrasound renal denervation
effectively and consistently reduced sympathetic activity acutely in a preclinical
model and in a small subset of patients providing evidence that the technology is
performing as intended in vivo.
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Background: Catheter-based renal denervation (RDN) causes signiﬁcant blood
pressure (BP) reductions in patients with resistant hypertension. The purpose of this
study was to identify predictors of BP response.
Methods: This is a single-center, non-randomized, uncontrolled retrospective analysis
of hypertensive patients. One hundred one consecutive patients with resistant hyper-
tension who underwent RDN with the Symplicity catheter were included. Uni- and
multivariate logistic regression analyses were performed to detect baseline predictors
of a signiﬁcant BP response 6 months after RDN (age, gender, ofﬁce and ambulatory
BP, renal function, body mass index [BMI], diabetes mellitus, antihypertensive
medication, number of ablations). Primary endpoint was the change in average ofﬁce
BP at 6-month follow-up compared to baseline and between groups.
Results: The patients included in this study were 61 males and 40 females, with a
median age of 62.8  11.0 years. The procedure was technically uneventful in all
patients. Mean BP at baseline was 166.6/90.2  22.5/16.4 mmHg and decreased by
-14.7 (p< 0.0001) /-5.3 (p< 0.001)  22.8/14.1 mmHg at 6-month follow-up.
Similarly, paired analysis of 24 hour-ambulatory blood pressure measurement (n¼71)
showed a signiﬁcant reduction of mean systolic BP by 6.8  14.4 mmHg (p< 0.0002).pertension Therapies Including Renal Denervation B121
